Medline Inc.
L10
| 03/28/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -5.59% | 9.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -5.59% | 9.44% | |||
| Cost of Revenue | -6.16% | 12.08% | |||
| Gross Profit | -3.81% | 2.08% | |||
| SG&A Expenses | -1.11% | 13.35% | |||
| Depreciation & Amortization | 0.00% | -0.56% | |||
| Other Operating Expenses | -50.00% | 275.00% | |||
| Total Operating Expenses | -5.32% | 12.28% | |||
| Operating Income | -9.93% | -22.82% | |||
| Income Before Tax | 41.26% | -40.29% | |||
| Income Tax Expenses | 100.00% | 13.04% | |||
| Earnings from Continuing Operations | 32.78% | -44.10% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -5,600.00% | -- | |||
| Net Income | -29.12% | -43.48% | |||
| EBIT | -9.93% | -22.82% | |||
| EBITDA | -7.24% | -14.87% | |||
| EPS Basic | -29.91% | 1,121.20% | |||
| Normalized Basic EPS | -59.24% | 1,609.52% | |||
| EPS Diluted | -29.91% | 1,121.20% | |||
| Normalized Diluted EPS | -59.56% | 1,609.52% | |||
| Average Basic Shares Outstanding | 1.12% | -95.37% | |||
| Average Diluted Shares Outstanding | 1.83% | -95.37% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | 0.43% | |||